Identification of mechanisms underlying atrial fibrillation and effective therapies at The University of Manchester on FindAPhD.com

Dr X Wang , Dr Vicky Liu Applications accepted all year round Self-Funded PhD Students Only

Email institution

Institution website

Add to
shortlist

Remove from
shortlist

COVID-19 Information

Email institution

Manchester United Kingdom Molecular Biology Pharmacology / Toxicology Physiology & Sports Science

Faculty of Biology, Medicine and Health, The University of Manchester

About the Project

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice with particular high prevalence in aged populations. To understand the mechanisms underlying the development of AF is crucial for developing effective therapy for AF. As part of electrical remodeling, gap junction remodeling leading to electrical perturbation favours the recurrence or perpetuation of AF. However, the underlying signalling mechanism is largely unknown. Using tissue specific conditional knockout technique, we have established a number of atrium-specific knockout mouse models in which the components of the MAP kinases are specifically deleted in atrial cardiomyocytes. The aim of this project is to determine the role of MAP kinase signalling pathway in atria and in relation to atrial arrhythmogenesis. Novel mathematical models will be generated in this project as tools to determine the key aetiological factor in atrial fibrillation, and to identify molecular targets for the treatment of AF.

This project will provide a comprehensive training for a PhD student in a wealth of molecular and cellular approaches, in vivo cardiac functional study on genetically modified mice, electrophysiology and computational simulation methods.

Funding Notes

This project has a Band 2 fee. Details of our different fee bands can be found on our website (View Website). For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (View Website).

Informal enquiries may be made directly to the primary supervisor.

References

Liu W, Zi M, Naumann R, Ulm S, Jin J, Taglieri DM, Prehar S, Gui J, Xiao R, Neyses L, Soralo RJ, Ke Y, Cartwright EJ, Lei M, Wang X. Pak1 is a novel signaling regulator attenuating cardiac hypertrophy in mice. Circulation. 2011;124(24):2702-2715.

Liu W, Zi M, Chi H., Jin J, Prehar S, Neyses L, Cartwright EJ, Flavell RA, Davis RJ, Wang X. Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload. J Mol Cell Cardiol. 2011;50 (4):702-711.

Kimura TE, Jin JW, Zi M, Prehar S, Liu W, Oceandy D, Abe JI, Neyses L, Weston AH, Cartwright EJ, Wang X. Targeted Deletion of the Extracellular Signal-Regulated Protein Kinase 5 Attenuates Hypertrophic Response, and Promotes Pressure Overload-Induced Apoptosis in the Heart. Circ Res. 2010;106:961-970.

Liu W, Zi M, Jin JW, Prehar S, Oceandy D, Kimura TE, Lei M, Neyses L, Weston AH, Cartwright EJ, Wang X. Cardiac-Specific Deletion of Mkk4 Reveals Its Role in Pathological Hypertrophic Remodeling, but Not in Physiological Cardiac Growth. Circ Res. 2009;104:904-914.

Zi M, Kimura TE, Liu W, Jin J, Higham J, Kharche S, Hao G, Shi Y, Shen W, Prehar S, Mironov A, Neyses L, Bierhuizen MFA, Boyett MR, Zhang H, Cartwright EJ, Lei M, Wang X. MKK4 deficiency in cardiomyocytes causes connexin 43 remodeling and couples hypertrophic signals to ventricular arrhythmogenesis. J Biol Chem. 2011;286:17821-17830.

Wang, X. (2009) Cre transgenic mouse lines. In Transgenesis, 3rd Edition. Editor: Elizabeth J. Cartwright. Methods Mol Biol. 561, 265-273.

Cartwright, E.J. and Wang, X. (2009) Transgenesis. Molecular Biology and Biotechnology. Editor: JM Walker and R Rapley. 5th Edition, 1-10.

Egom E, Mohamed T, Mamas M, Shi Y, Liu W, Chirico D, Stringer S, Ke Y, Shaheen M, Wang T, Chacko S, Wang X, Solaro S, Fath-Ordoubadi F, Cartwright E, Lei M. Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of amechanism protecting cardiomyocytes against ischemic cell injury. Am J Phyiology. 2011;301(4):H1487-H1495.

Email Now

Recipient *

Your first name *

Your last name *

Your telephone number

Your e-mail address *

Your CV (2MB limit)

Where are you currently living? *

Your nationality *

Your message * (please edit as appropriate)

Insert previous message below for editing?

You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here

The information you submit to The University of Manchester will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.

* required field

Send a copy to me for my own records.

Your enquiry has been emailed successfully

Search Suggestions

Based on your current searches we recommend the following search filters.

Check out our other PhDs in Manchester, United Kingdom

Check out our other PhDs in Physiology & Sports Science

Start a new search with our database of over 4,000 PhDs

PhD Suggestions

Based on your current search criteria we thought you might be interested in these.

Myocardial biology with a specific focus on the mechanisms underlying cardiac fibrosis and atrial fibrillation
University of Oxford

Sequence variation and epigenomic mechanisms underlying human neuropsychiatric and neurodegenerative diseases
University of Nottingham

Understanding the mechanisms underlying cognitive training effects
University of Sheffield

Our Sites

Main Menu

Identification of mechanisms underlying atrial fibrillation and effective therapies

The University of Manchester Faculty of Biology, Medicine and Health

About the Project

Funding Notes

References